Oracle Investment Management Inc Biocryst Pharmaceuticals Inc Call Options Transaction History

Oracle Investment Management Inc

  • $43.2 Million
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$10.79 - $14.81 $1.08 Million - $1.48 Million
-100,000 Reduced 28.57%
250,000 $281,000
Q2 2022

Aug 15, 2022
BUY
$7.89 - $17.88 $1.58 Million - $3.58 Million
200,000 Added 133.33%
350,000 $656,000
Q3 2021

Nov 15, 2021
BUY
$14.21 - $17.65 $2.13 Million - $2.65 Million
150,000 New
150,000 $176,000

Others Institutions Holding BCRX

# of Institutions
278
Shares Held
172M
Call Options Held
625K
Put Options Held
739K
View Full List

About BIOCRYST PHARMACEUTICALS INC

BCRX Quotes by TradingView
  • Ticker BCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,944,992
  • Market Cap $1.45B
  • Description
  • BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...
More about BCRX
Track This Portfolio

Track Oracle Investment Management Inc Portfolio

Follow Oracle Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oracle Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oracle Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email